• Find a pharmacy

Find a local pharmacy

Search for a pharmacy that offers HEPLISAV-B, the only adult hepatitis B vaccine that provides protection with just 2 doses in 1 month.
Lat:
Lng:
within

Find HEPLISAV-B

City, state, or ZIP code

Radius

See search results below.

Find a pharmacy
Clear

No results found

Your search did not return any results.

Inclusion of pharmacy information in this finder is based on available data at the time of posting and does not guarantee supply, nor does it represent an endorsement, referral, or recommendation from Dynavax. Please be sure to contact the pharmacy of your choice to check their availability of HEPLISAV-B.
Map
INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see Full Prescribing Information.

INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see Full Prescribing Information.